App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden

Author:

Kennedy Beatrice,Fitipaldi HugoORCID,Hammar Ulf,Maziarz MarlenaORCID,Tsereteli Neli,Oskolkov Nikolay,Varotsis Georgios,Franks Camilla A.,Nguyen DiemORCID,Spiliopoulos Lampros,Adami Hans-OlovORCID,Björk JonasORCID,Engblom StefanORCID,Fall Katja,Grimby-Ekman Anna,Litton Jan-Eric,Martinell Mats,Oudin Anna,Sjöström Torbjörn,Timpka ToomasORCID,Sudre Carole H.,Graham Mark S.,du Cadet Julien Lavigne,Chan Andrew T.,Davies RichardORCID,Ganesh Sajaysurya,May Anna,Ourselin Sébastien,Pujol Joan Capdevila,Selvachandran Somesh,Wolf JonathanORCID,Spector Tim D.ORCID,Steves Claire J.ORCID,Gomez Maria F.ORCID,Franks Paul W.ORCID,Fall ToveORCID

Abstract

AbstractThe app-based COVID Symptom Study was launched in Sweden in April 2020 to contribute to real-time COVID-19 surveillance. We enrolled 143,531 study participants (≥18 years) who contributed 10.6 million daily symptom reports between April 29, 2020 and February 10, 2021. Here, we include data from 19,161 self-reported PCR tests to create a symptom-based model to estimate the individual probability of symptomatic COVID-19, with an AUC of 0.78 (95% CI 0.74–0.83) in an external dataset. These individual probabilities are employed to estimate daily regional COVID-19 prevalence, which are in turn used together with current hospital data to predict next week COVID-19 hospital admissions. We show that this hospital prediction model demonstrates a lower median absolute percentage error (MdAPE: 25.9%) across the five most populated regions in Sweden during the first pandemic wave than a model based on case notifications (MdAPE: 30.3%). During the second wave, the error rates are similar. When we apply the same model to an English dataset, not including local COVID-19 test data, we observe MdAPEs of 22.3% and 19.0% during the first and second pandemic waves, respectively, highlighting the transferability of the prediction model.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference41 articles.

1. World Health Organization. Public health surveillance for COVID-19: Interrim Guidance. 16 December 2020. Available at https://apps.who.int/iris/bitstream/handle/10665/337897/WHO-2019-nCoV-SurveillanceGuidance-2020.8-eng.pdf (2020).

2. European Centre for Disease Prevention and Control. COVID-19 surveillance guidance. October 2021. Available at https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-surveillance-guidance.pdf (2021).

3. Denis, F. et al. Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: analysis of data from a self-assessment web application. J. Med. Internet Res. 22, e19855 (2020).

4. Timmers, T., Janssen, L., Stohr, J., Murk, J. L. & Berrevoets, M. A. H. Using eHealth to Support COVID-19 Education, Self-Assessment, and Symptom Monitoring in the Netherlands: Observational Study. JMIR Mhealth Uhealth 8, e19822 (2020).

5. Yoneoka, D. et al. Early SNS-Based Monitoring System for the COVID-19 Outbreak in Japan: a Population-Level Observational Study. J. Epidemiol. 30, 362–370 (2020).

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3